SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

Evotec-Bristol Myers Squibb Partnership Gets Second FDA IND Acceptance

Evotec said its protein degradation collaboration with Bristol Myers Squibb received a second FDA investigational new drug acceptance.

EVO

Related stories